Avoid and Resist Strategies for Weight Management

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Dec 1, 2026 → Feb 2027
See other at-risk trials from Cedars-Sinai Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion pushed from Dec 1, 2026 to Feb 2027
    • Study completion date: Feb 9, 2027 to Feb 2027
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v14
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 500 to confirmed 503
    • Site details revised
    v13
  4. Primary completion date: Jun 6, 2026 to Dec 1, 2026v12
  5. Re-verified, no change to tracked fieldsv11
Show 9 earlier versionsHide 9 earlier versions
  1. Primary completion date: Dec 1, 2026 to Jun 6, 2026
    • Eligibility criteria expanded, about 32 words
    • Study description revised
    • Collaborators: 4 to 5
    v10
  2. Collaborators: 3 to 4v9
  3. Start date: Feb 10, 2022 to Jun 6, 2022v8
  4. Study completion date: Mar 1, 2027 to Feb 9, 2027
    • Start date: Jun 1, 2022 to Feb 10, 2022
    v7
  5. Primary completion date: Nov 10, 2026 to Dec 1, 2026
    • Study completion date: Feb 10, 2027 to Mar 1, 2027
    v6
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 10, 2022 to Jun 1, 2022
    • Secondary endpoints: 2 to 1
    • Site details revised
    v5
  7. Start date: Jan 24, 2022 to May 10, 2022v4 Show 4 more changesShow less
    • Primary completion date: Jul 24, 2026 to Nov 10, 2026
    • Study completion date: Jan 24, 2027 to Feb 10, 2027
    • Eligibility criteria revised
    • Study description revised
  8. Primary completion date: Nov 1, 2026 to Jul 24, 2026
    • Study completion date: Apr 1, 2027 to Jan 24, 2027
    • Start date: Apr 1, 2022 to Jan 24, 2022
    v3
  9. Start date: Jan 1, 2022 to Apr 1, 2022
    • Primary completion date: Jul 1, 2026 to Nov 1, 2026
    • Study completion date: Jan 1, 2027 to Apr 1, 2027
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed randomized controlled trial tests two self-regulatory approaches to improve intentional weight loss and diet quality in individuals with overweight or obesity: (1) an environmental control strategy (AVOID) and (2) an impulse control training strategy (RESIST).
Trial Details
NCT Number NCT05143931
Lead Sponsor Cedars-Sinai Medical Center
Collaborators: University of California, Riverside, WW International Inc, The University of Tennessee, Knoxville, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Northeastern University
Conditions
(from sponsor)		 Obesity, Overweight
Related terms Obesity, Overweight
Enrollment 503 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov